ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh RSMDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RSMDF is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $19.17
- Day Range
- $19.06–19.06
- 52-Week Range
- $13.72–22.46
- Bid/Ask
- $17.48 / $19.36
- Market Cap
- $28.04 Bil
- Volume/Avg
- 305,617 / 141,130
Key Statistics
- Price/Earnings (Normalized)
- 28.03
- Price/Sales
- 6.24
- Dividend Yield (Trailing)
- 0.99%
- Dividend Yield (Forward)
- 1.01%
- Total Yield
- 1.00%
Company Profile
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 10,140
- Website
- https://www.resmed.com
Competitors
Valuation
|
Metric
|
RSMDF
|
FPH
|
CTEC
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.03 | 57.28 | 24.57 |
Price/Book Value | 6.26 | 8.74 | 4.41 |
Price/Sales | 6.24 | 8.99 | 3.40 |
Price/Cash Flow | 23.25 | 39.12 | 19.52 |
Price/Earnings
RSMDF
FPH
CTEC
Financial Strength
|
Metric
|
RSMDF
|
FPH
|
CTEC
|
|---|---|---|---|
Quick Ratio | 1.23 | 1.06 | 0.79 |
Current Ratio | 3.11 | 2.54 | 1.62 |
Interest Coverage | 19.71 | 25.77 | 3.21 |
Quick Ratio
RSMDF
FPH
CTEC
Profitability
|
Metric
|
RSMDF
|
FPH
|
CTEC
|
|---|---|---|---|
Return on Assets (Normalized) | 14.83% | 12.48% | 7.44% |
Return on Equity (Normalized) | 24.40% | 16.75% | 16.69% |
Return on Invested Capital (Normalized) | 18.31% | 15.46% | 10.90% |
Return on Assets
RSMDF
FPH
CTEC
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Qytlfhkfy | Zqzb | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Lmwtjrqwl | Pvxpswr | $67.9 Bil | |
ALC
| Alcon Inc | Bjkphthlk | Jcpgqfj | $40.4 Bil | |
CLPBY
| Coloplast A/S ADR | Srvjpfqs | Rrfv | $29.4 Bil | |
WST
| West Pharmaceutical Services Inc | Tbzkwcrlc | Cjjk | $28.5 Bil | |
RMD
| ResMed Inc | Jxqdcmckwb | Rllbps | $27.2 Bil | |
BAX
| Baxter International Inc | Xvhjlrj | Qpzfvx | $20.4 Bil | |
COO
| The Cooper Companies Inc | Mtzxmmplw | Cmvfcv | $18.3 Bil | |
HOLX
| Hologic Inc | Ljjrbjl | Qnzrw | $18.2 Bil | |
TFX
| Teleflex Inc | Qkzcc | Qybg | $9.9 Bil |